Geriatrics addresses the health needs of older adults, focusing on frailty, dementia, falls, and chronic disease management.
Send us all your questions or requests, and our expert team will assist you.
How do we accurately identify depression in a brain that is also undergoing the natural processes of aging? In geriatric medicine, the diagnosis of depression is a sophisticated process of Differential Mapping. Because symptoms like forgetfulness, fatigue, and social withdrawal overlap with early-stage dementia or systemic illness, a simple psychological evaluation is insufficient. At Liv Hospital, we move beyond subjective questionnaires to identify the “Biological Signature” of the depressive state.
Our diagnostic framework is designed to separate Neuro-plastic Decline from permanent neurodegenerative damage. By analyzing the brain’s vascular integrity and metabolic environment, we can determine if a patient’s symptoms are driven by chemical imbalances, “Silent Strokes,” or nutritional deficiencies. This precision ensures that treatment targets the root biological cause, facilitating a true restoration of mood and cognitive clarity.
Modern diagnosis leverages Structural MRI to create a physical map of the brain’s health. We are no longer looking just for “sadness”; we are looking for the biological drivers of a failed adaptation. At Liv Hospital, we specifically focus on two critical anatomical markers:
White Matter Hyperintensities (WMH): Identifying areas of reduced blood flow. The presence of these “leukoaraiosis” spots provides physical evidence of Vascular Depression, confirming that the mood disorder is rooted in vascular health.
Beyond imaging, the evaluation delves into the molecular realm with comprehensive biomarker panels. Blood, urine, and saliva are analyzed to assess a vast array of physiological metrics. Key among these is the evaluation of neurotrophic factors, such as Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth Factor. Low levels of these proteins serve as critical indicators of the brain’s reduced capacity for repair and maintenance. Additionally, inflammatory markers such as C-reactive protein, homocysteine, and various interleukins are measured to determine the inflammatory burden on the brain.
This granular analysis allows the clinical team to diagnose inflammaging as a specific biological driver of the patient’s depressive symptoms. It separates biological depression from purely psychosocial causes and guides anti-inflammatory interventions. Furthermore, metabolic profiling is performed to assess insulin resistance, vitamin deficiencies, and mitochondrial markers. This ensures that any metabolic blockades preventing energy production in the brain are identified and addressed.
Genetic and epigenetic testing form another pillar of the diagnostic architecture. Understanding a patient’s genetic predispositions such as variations in the MTHFR gene, which affects methylation and neurotransmitter synthesis provides invaluable context regarding their susceptibility to mood disorders and their ability to metabolize medications. However, modern diagnostics go further, examining epigenetic markers that reveal how lifestyle and environment have influenced gene expression. This includes measuring telomere length to assess cellular biological age versus chronological age.
A patient with depression may exhibit accelerated cellular aging, a finding that immediately directs the care pathway toward aggressive anti-aging and regenerative interventions. This genomic insight transforms the diagnosis from a static label into a dynamic understanding of gene-environment interactions. It allows the clinician to see not just the genes the patient was born with, but also how those genes are behaving in real time, offering targets for intervention that can reverse negative epigenetic expression.
In the geriatric population, depression is often a “downstream” effect of a systemic metabolic failure. We conduct extensive blood panels to ensure that the patient is not suffering from a reversible physical condition that mimics psychiatric symptoms.
Send us all your questions or requests, and our expert team will assist you.
In seniors, “feeling down” is often the first sign of physical changes in the brain, such as small vessel disease or micro-strokes. An MRI allows us to see if your depression is vascular in nature, which changes how we treat it.
Yes. Through neuropsychological testing and imaging, we can see if your memory loss is caused by a chemical/inflammatory “fog” (depression) or by the physical plaques and tangles of Alzheimer’s. Depression-related memory loss is often reversible.
Absolutely. Chronic high blood pressure can damage the brain’s white matter, leading to Vascular Depression. Part of our diagnostic process is evaluating your cardiovascular history as a primary driver of your mood.
Vitamin B12 is essential for the health of your nerves and the production of mood-regulating chemicals. A deficiency can cause symptoms that look identical to clinical depression, including fatigue and memory problems.
This is common in the “Silent Generation.” We focus on the physical and cognitive symptoms such as unexplained pain, sleep issues, or memory fog to reach a diagnosis, even if the patient doesn’t feel “sad.”
Your Comparison List (you must select at least 2 packages)
